COVID-19 Pediatric

COVID Vaccinations for Children are Available Now at IH21!

Register Online or Call 1.800.451.6889, Option 1

FDA & CDC Announcements:

October 29, 2021
FDA Announces Authorization of Pfizer BioNTech Covid-19 Vaccine for Emergency use in Children Ages 5-11.

November 2, 2021
Centers for Disease Control and Prevention (CDC) recommend all children ages 5-11 receive two dose series of Pfizer BioNTech Covid-19 vaccine.

Key points for parents and caregivers:

Effectiveness: Immune responses of children 5 through 11 years of age were comparable to those of individuals 16 through 25 years of age. In addition, the vaccine was found to be 90.7% effective in preventing COVID-19 in children 5 through 11.
Safety: The vaccine’s safety was studied in approximately 3,100 children age 5 through 11 who received the vaccine and no serious side effects have been detected in the ongoing study.

The Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age is administered as a two-dose primary series, 3 weeks apart, but is a lower dose (10 micrograms) than that used for individuals 12 years of age and older (30 micrograms).

Side effects among children who recive this vaccine are very similar to side effects observed in the adult population including pain at the injection site, low grade fever, chills, headache, body aches and fatigue which usually resolves within 1-3 days.

Other COVID-19 SERVICES WE OFFER: